SciELO - Scientific Electronic Library Online

 
vol.80 suppl.1Pulmonary embolism in an adolescent with COVID-19 pneumoniaClinical and molecular heterogeneity in CDLK5 disorders author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Boletín médico del Hospital Infantil de México

Print version ISSN 1665-1146

Abstract

GOITIA-CARDENAS, Mariana; AZOTLA-VILCHIS, Coztli O.  and  MIRANDA-LORA, América L.. Robinow syndrome and its response to growth hormone treatment. Bol. Med. Hosp. Infant. Mex. [online]. 2023, vol.80, suppl.1, pp.40-46.  Epub Sep 11, 2023. ISSN 1665-1146.  https://doi.org/10.24875/bmhim.22000101.

Background:

Robinow syndrome is a rare disease with short stature, characteristic phenotypical abnormalities, and intellectual integrity in most cases.

Case report:

We present the case of a 13-year and one-month-old male who came for medical consultation at 3 years of age due to short stature. Additionally, the patient showed craniofacial dysmorphia, congenital heart disease, and growth hormone deficiency. As per family history, the mother presented the same phenotype. The genetic study identified an unreported variant of the WNT5A gene.

Conclusions:

The patient initiated growth hormone treatment at a dose of 0.7 U/kg/week at 4 years of age with favorable results, increasing his height from the < 1st percentile to the 44th percentile.

Keywords : Robinow syndrome; Growth hormone; WNT5A gene.

        · abstract in Spanish     · text in English     · English ( pdf )